Biotech Business - May 31, 2023
Anocca raises 400 million SEK
The capital injection will be used to further develop the company’s unique process that enables discovery and manufacture of next generation cell therapies for cancer on an industrial scale. The financing also allows Anocca to progress the company’s first products into clinical trials, it states. “In recent years, we have made great progress in automating […]
Financing - May 24, 2023
Gedea Biotech raises 1.3 million EUR
The money has been raised for additional development activities of their product pHyph for antibiotic free treatment of vaginal infections. The funds will be used for an ongoing proof-of-concept study for the treatment of Vulvo Vaginal Candidiasis (VVC) with pHyph, partially financed by a recent grant from Swelife and Medtech4Health, investigating how the vaginal microbiome […]
Financing - May 15, 2023
Capitainer secures 5.7 million USD
The company will use the financing to expand and commercialize its self-sampling technology for remote healthcare solutions and personalized medicine. The funding will be used to increase production capacity, develop new products, and intensify sales and marketing efforts. The investment round was led by Sciety and the network Sciety Venture Partners. Sciety and its network […]
Financing - April 19, 2023
MedVasc closes investment round of 3 million SEK
The investors include several life science investors such as Life Science Invest Gamma, but also existing and new private investors. The raised capital will mainly be used for final product development and for preparing an FDA 510k application for the company’s anesthesia catheter Solutio. Solutio minimizes the pain of implementing the golden standard methods for […]
Biotech Business - April 4, 2023
Gedea Biotech awarded 3 million SEK
The company has been awarded a grant from the Swedish innovation programs, SWElife and MedTech4Health in a collaboration with Danderyd hospital, Huddinge hospital and Karolinska Institute. The grant will fund a further clinical trial of its antibiotic free treatment pHyph for the treatment of vulvovaginal candida infections (VVC). The new study, involving 26 patients with VVC […]
Biotech Business - April 4, 2023
Modus has secured access to bridge financing of up to 7 MSEK
Modus Therapeutics secures access to bridge financing from longstanding investor Karolinska Development. Access to this funding ensures that momentum of clinical development of Modus’ lead asset, sevuparin, will be enhanced while the company continues to explore licensing and partnership opportunities, it states. These future development plans include preparation for a Phase 2a study evaluating sevuparin […]
